You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Isolation and characterization of a primary breast epithelium transforming agent
SBC: SkinAxis LLC Topic: 102Abstract Breast cancer BC is the most common cancer among women Viruses have long been suspected as a cause of breast cancer However despite the identification of virions in human BC cells and human milk and numerous studies that suggest possible connection between breast cancer and Epstein Barr virus EBV mouse mammary tumor virus MMTV and human papilloma virus HPV the tumorigenic po ...
SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Development of PEGylated MTI for the treatment of relapsed Myeloma
SBC: MODULATION THERAPEUTICS, INC. Topic: 102ABSTRACT Modulation Therapeutics is developing a first in class cyclic peptide coined MTI for the treatment of multiple myeloma The company currently has a license for the parent molecule which has been awarded a patent covering the intellectual property for both composition of matter and use in cancer in the US and Europe Modulation Therapeutics is now poised to further advance this class ...
SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
An Improved Method of Delivering a Sclerosing Agent for the Treatment of a Malignant Pleural Effusion
SBC: TDL INNOVATIONS LLC Topic: 102Project Summary We are developing an improved clinical method to treat patients with malignant pleural effusions A pleural effusion is an abnormal build up of fluid in the pleural cavity the fluid space that surrounds the lungs These malignant pleural effusions MPE occur in patients in the US each year affecting between to of all cancer patients Management of a MPE is p ...
SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Method for High Throughput Assembly of Long DNA Fragments in vitro
SBC: Pharmaseq, Inc Topic: 200SUMMARY The main project goal is to develop principles and demonstrate the feasibility of a fast in vitro method that will increase the length of synthetic double stranded DNA from its current limit of about kb to kb This in turn will facilitate the ability to more rapidly create artificial genes and chromosomes and thus become an important tool in synthetic biology The proposed approac ...
SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Development of a novel combination of anti-septic taurolidine encased in a digestible nanoparticle system for use as topical treatment at burn sites
SBC: CorMedix Inc. Topic: 300ABSTRACT Burn injury care has improved in the past decadesbut complications still occur and lead to prolonged hospital stays and potentially to deathThe risk of infection rises as a result of burns since the skin layerswhich function as a barrier and prevent pathogens from accessing the susceptible body tissuesare no longer intactImportantlyinfections involving gram negative or gram positive patho ...
SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
EVVS Endoscopic Venous Valve System
SBC: VENARUM MEDICAL LLC Topic: NHLBIProject Summary Abstract Venarum Medical LLC Venarum proposes to validate the Endoscopic Venous Valve System EVVS a novel patent pending valve replacement solution for serious complications of chronic venous disease CVD such as chronic venous insufficiency CVI and specifically dysfunctional venous valves This device is based on the principle that a nitinol stent like scaffold embe ...
SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Feasibility of a mobile parent based intervention to reduce alcohol use by high school seniors
SBC: REAL PREVENTION LLC Topic: 350The goal of this SBIR proposal is to demonstrate the feasibility of an interactive tailored e learning parent based intervention PBI m for parents of high school seniors that aims to reduce alcohol use and related harm among teens during the post high school transition an established high risk period The proposed PBI m is adapted from an evidence based curriculum in four important ways ...
SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Interstitial Intensity Modulated Photodynamic Therapy i IMPDT
SBC: SIMPHOTEK, INC. Topic: 102Over worldwide cases of head and neck Handamp N cancer occur annually Despite aggressive treatment about of Handamp N cancers recur and progress Recent studies of interstitial PDT I PDT have shown promising results in the treatment of patients with locally advanced Handamp N cancer that fail standard therapies I PDT provides a means to treat cancerous tumors while minimizing da ...
SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Developing an integrated sorting and single cell analysis tool for the analysis of rare T Cells subsets in Autoimmunity
SBC: ISOPLEXIS CORPORATION Topic: RAutoimmune disease AD affects up to million Americans which costs approximately $ billion on health care annually and accounts for one of the leading causes of death in women T cells and cytokine function play an important role in autoimmune diseases such as Type Diabetes Multiple Sclerosis Rheumatoid Arthritis RA and Systemic Lupus Erythematosus SLE The most successful auto i ...
SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Protein therapeutic to facilitate healing of chronic wounds
SBC: TRIM-EDICINE INC Topic: 300Project Summary This Phase I SBIR proposal targets the development of recombinant human MG rhMG a novel tissue repair protein as a topical therapeutic candidate to facilitate healing of chronic wounds Wound care represents a challenging problem to the public health as no effective treatments for chronic non healing wounds are available MG is an essential component of the cell membrane ...
SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health